The Journal of
Clinical Psychiatry

Depression (MDD)

Article August 30, 2000

Introduction. Norepinephrine: Neurotransmitter for the Millennium

Charles B. Nemeroff, MD, PhD

J Clin Psychiatry 2000;61(suppl 10):3-4

Article Abstract

Download Free PDF

This PDF is free for all visitors!

Save

Cite

INFORMATION FROM INDUSTRY

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY is thought to work and side effects. Please see Important Safety Information within this document and the full Prescribing Information.

Vol 85 • 2024 • Number 4

Read the Current Issue

Meta-Analysis

Changes in Cognition in Patients With Schizophrenia

Systematic Review

Diagnostic Assessment via Telehealth vs Face-to-Face

Original Research

Prevalence, Correlates, and Burden of Subthreshold PTSD in US Veterans

Original Research

Bridge Symptoms Between Borderline Personality and PTSD

Original Research

Gepirone-ER and Sexual Function in Patients with MDD

Original Research

Medication Use and Lines of Treatment in Patients With Insomnia Disorder

View current Issue

Article

Brain Zaps

December 20, 2018

Brain zaps are a poorly understood symptom of antidepressant discontinuation, which require further study for both better prevention and treatment. This article describes the characteristics of brain zaps and...

Alexander Papp , Julie A. Onton

Article

ECT in Obsessive-Compulsive-Related Disorders

October 18, 2018

Obsessive-compulsive-related disorders include conditions such as body dysmorphic disorder and skin-picking disorder, as well as tic disorders and self-injurious behaviors. Could electroconvulsive therapy be an effective treatment option? Read...

Samara dos Santos-Ribeiro , Juliana B. de Salles Andrade , Julliana N. Quintas , et al

Article

Glabellar Botulinum for Depression

October 4, 2018

Glabellar injection of botulinum toxin A (BTA) provides a novel and interesting strategy to address shortcomings in the treatment of depression. This study examines the primary clinical trials conducted...

Toren P. Stearns , Mujeeb U. Shad , Gabriela C. Guzman

Introduction. Norepinephrine: Neurotransmitter for the Millennium

Read the Current Issue

Changes in Cognition in Patients With Schizophrenia

Diagnostic Assessment via Telehealth vs Face-to-Face

Prevalence, Correlates, and Burden of Subthreshold PTSD in US Veterans

Bridge Symptoms Between Borderline Personality and PTSD

Gepirone-ER and Sexual Function in Patients with MDD

Medication Use and Lines of Treatment in Patients With Insomnia Disorder

ELSEWHERE:

FOLLOW US:

Introduction. Norepinephrine: Neurotransmitter for the Millennium

Read the Current Issue

Changes in Cognition in Patients With Schizophrenia

Diagnostic Assessment via Telehealth vs Face-to-Face

Prevalence, Correlates, and Burden of Subthreshold PTSD in US Veterans

Bridge Symptoms Between Borderline Personality and PTSD

Gepirone-ER and Sexual Function in Patients with MDD

Medication Use and Lines of Treatment in Patients With Insomnia Disorder

Related Articles

Brain Zaps

ECT in Obsessive-Compulsive-Related Disorders

Glabellar Botulinum for Depression

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles